116 related articles for article (PubMed ID: 3078575)
1. Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.
Evans DJ; Evans DG; Opekun AR; Graham DY
FEMS Microbiol Immunol; 1988 Jan; 1(1):9-18. PubMed ID: 3078575
[TBL] [Abstract][Full Text] [Related]
2. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes.
Evans DG; Evans DJ; Opekun AR; Graham DY
FEMS Microbiol Immunol; 1988 Dec; 1(3):117-25. PubMed ID: 3078739
[TBL] [Abstract][Full Text] [Related]
3. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
Evans DG; Graham DY; Evans DJ
Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
[TBL] [Abstract][Full Text] [Related]
4. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
[TBL] [Abstract][Full Text] [Related]
6. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
7. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
Tacket CO; Reid RH; Boedeker EC; Losonsky G; Nataro JP; Bhagat H; Edelman R
Vaccine; 1994 Nov; 12(14):1270-4. PubMed ID: 7856290
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
McKenzie R; Bourgeois AL; Engstrom F; Hall E; Chang HS; Gomes JG; Kyle JL; Cassels F; Turner AK; Randall R; Darsley M; Lee C; Bedford P; Shimko J; Sack DA
Infect Immun; 2006 Feb; 74(2):994-1000. PubMed ID: 16428745
[TBL] [Abstract][Full Text] [Related]
9. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
Wennerås C; Svennerholm AM; Ahrén C; Czerkinsky C
Infect Immun; 1992 Jul; 60(7):2605-11. PubMed ID: 1612730
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine.
Jertborn M; Ahrén C; Svennerholm AM
Clin Diagn Lab Immunol; 2001 Mar; 8(2):424-8. PubMed ID: 11238232
[TBL] [Abstract][Full Text] [Related]
11. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
13. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
Levine MM; Black RE; Brinton CC; Clements ML; Fusco P; Hughes TP; O'Donnell S; Robins-Browne R; Wood S; Young CR
Scand J Infect Dis Suppl; 1982; 33():83-95. PubMed ID: 6127806
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults.
Cohen D; Orr N; Haim M; Ashkenazi S; Robin G; Green MS; Ephros M; Sela T; Slepon R; Ashkenazi I; Taylor DN; Svennerholm AM; Eldad A; Shemer J
Infect Immun; 2000 Aug; 68(8):4492-7. PubMed ID: 10899847
[TBL] [Abstract][Full Text] [Related]
15. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a single oral dose of a live bivalent E. coli vaccine against post-weaning diarrhea due to F4 and F18-positive enterotoxigenic E. coli.
Nadeau É; Fairbrother JM; Zentek J; Bélanger L; Tremblay D; Tremblay CL; Röhe I; Vahjen W; Brunelle M; Hellmann K; Cvejić D; Brunner B; Schneider C; Bauer K; Wolf R; Hidalgo Á
Vet J; 2017 Aug; 226():32-39. PubMed ID: 28911838
[TBL] [Abstract][Full Text] [Related]
17. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
19. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
20. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
